Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
AbbVie Inc.
C C C C C C C A C A A C A C C A C C C C A C
C07D C07D C07D C07D C07K C07D C07D A61P C07D A61P A61P C07D A61P C07C C07C A61P C07D C07C C07D C07D A61P C07F
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
David A. Kathy Daniel D. Dachun Mark A. Ryan G. John T. Mary E. Clarence J. William A. Jean C. Douglas K. David A. Pamela L. Warren M. Lissa T. Kevin R. Rolf Yi Christopher E. Wenke Todd W. Charles W. Charles A. Allan C. John K. Michael D. Seble H. Sachin V. Tammie K.
DeGoey Sarris Caspi Liu Matulenko Keddy Randolph Bellizzi Maring Carroll Califano Hutchinson Betebenner Donner Kati Nelson Woller Wagner Gao Motter Li Rockway Hutchins Flentge Krueger Pratt Tufano Wagaw Patel Jinkerson